Antengene
Mr. Lung has more than 16 years of experience in investment banking and public equities, including at Goldman Sachs and BFAM Partners. Mr. Lung invested across sectors, including in the healthcare and biotech industry at BFAM Partners.
This person is not in any offices
Antengene
Driven by its vision of “Treating Patients Beyond Borders”, Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world.